Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Multicomponent phytotherapeutic approach gaining momentum: Is the "one drug to fit all" model breaking down?

Rather MA, Bhat BA, Qurishi MA.

Phytomedicine. 2013 Dec 15;21(1):1-14. doi: 10.1016/j.phymed.2013.07.015. Epub 2013 Sep 12. Review.

PMID:
24035674
2.

Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy.

Efferth T, Koch E.

Curr Drug Targets. 2011 Jan;12(1):122-32. Review.

PMID:
20735354
3.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
4.

Multi-target therapeutics: when the whole is greater than the sum of the parts.

Zimmermann GR, Lehár J, Keith CT.

Drug Discov Today. 2007 Jan;12(1-2):34-42. Epub 2006 Nov 28. Review.

PMID:
17198971
5.

[Design of multiple targeted drugs].

Guo YS, Guo ZR.

Yao Xue Xue Bao. 2009 Mar;44(3):276-81. Review. Chinese.

PMID:
19449524
6.

Anticancer Drug Development: The Way Forward.

Connors T.

Oncologist. 1996;1(3):180-181.

7.

Guidelines, editors, pharma and the biological paradigm shift.

Singh AR, Singh SA.

Mens Sana Monogr. 2007 Jan;5(1):27-30. doi: 10.4103/0973-1229.32176.

8.

Cancer Drug Development: New Targets for Cancer Treatment.

Curt GA.

Oncologist. 1996;1(3):II-III.

PMID:
10387987
9.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
10.

Synergy research: approaching a new generation of phytopharmaceuticals.

Wagner H, Ulrich-Merzenich G.

Phytomedicine. 2009 Mar;16(2-3):97-110. doi: 10.1016/j.phymed.2008.12.018. Review.

PMID:
19211237
11.

[Prospects for development of new antituberculous drugs].

Tomioka H.

Kekkaku. 2002 Aug;77(8):573-84. Japanese.

PMID:
12235850
12.

Protein promiscuity: drug resistance and native functions--HIV-1 case.

Fernández A, Tawfik DS, Berkhout B, Sanders R, Kloczkowski A, Sen T, Jernigan B.

J Biomol Struct Dyn. 2005 Jun;22(6):615-24.

PMID:
15842167
13.
14.

New ways of insulin delivery.

Heinemann L.

Int J Clin Pract Suppl. 2010 Feb;(166):29-40. doi: 10.1111/j.1742-1241.2009.02276.x. Review.

PMID:
20377662
15.

Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.

Singh SS.

Curr Drug Metab. 2006 Feb;7(2):165-82. Review.

PMID:
16472106
17.

[Recent progress in mycobacteriology].

Okada M, Kobayashi K.

Kekkaku. 2007 Oct;82(10):783-99. Japanese.

PMID:
18018602
18.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
19.
20.

Pathway analysis for design of promiscuous drugs and selective drug mixtures.

Sivachenko A, Kalinin A, Yuryev A.

Curr Drug Discov Technol. 2006 Dec;3(4):269-77. Review.

PMID:
17430103

Supplemental Content

Support Center